NEUROCRINE BIOSCIENCES, INC. (NBIX) Operating cash flow 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$782.7MFY2025 · since FY2016: -$106.2M → $782.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $782.7M | +31.5% |
| FY2024 | $595.4M | +52.7% |
| FY2023 | $389.9M | +14.9% |
| FY2022 | $339.4M | +32.3% |
| FY2021 | $256.5M | +12.3% |
| FY2020 | $228.5M | +55.4% |
| FY2019 | $147.0M | +45.0% |
| FY2018 | $101.4M | +207.5% |
| FY2017 | -$94.3M | +11.2% |
| FY2016 | -$106.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX RevenueNBIX Net incomeNBIX Net marginNBIX Gross profitNBIX Gross marginNBIX Operating incomeNBIX Operating marginNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Stock buybacksNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →